0.691
4.03%
-0.029
After Hours:
.70
0.009
+1.30%
Venus Concept Inc stock is currently priced at $0.691, with a 24-hour trading volume of 36,671.
It has seen a -4.03% decreased in the last 24 hours and a -20.57% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.7292 pivot point. If it approaches the $0.6833 support level, significant changes may occur.
Venus Concept Inc Stock (VERO) Financials Data
Venus Concept Inc (VERO) Revenue 2023
VERO reported a revenue (TTM) of $82.51 million for the quarter ending September 30, 2023, a -23.49% decline year-over-year.
Venus Concept Inc (VERO) Net Income 2023
VERO net income (TTM) was -$36.05 million for the quarter ending September 30, 2023, a +5.42% increase year-over-year.
Venus Concept Inc (VERO) Cash Flow 2023
VERO recorded a free cash flow (TTM) of -$15.62 million for the quarter ending September 30, 2023, a +36.48% increase year-over-year.
Venus Concept Inc (VERO) Earnings per Share 2023
VERO earnings per share (TTM) was -$6.94 for the quarter ending September 30, 2023, a +23.31% growth year-over-year.
Venus Concept Inc Stock (VERO) Latest News
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
GlobeNewswire Inc.
Venus Concept Launches “NEXThetics” Program
GlobeNewswire Inc.
Venus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
GlobeNewswire Inc.
Gold Moves Lower; Pilgrim's Pride Earnings Top Views
Benzinga
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Crude Oil Gains 1%; US New Home Sales Increase In January
Benzinga
About Venus Concept Inc
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.
Cap:
|
Volume (24h):